Who Owns Gossamer Bio Stock?
NASDAQ: GOSSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 2:13 PM ET
Ownership breakdown
- Held by institutions
- 84.88%
- Held by insiders
- 1.43%
- Institutional holders
- 190
- Institutions 84.9%
- Insiders 1.4%
- Public and other 13.7%
Who owns Gossamer Bio stock?
Institutional investors own about 84.9% of Gossamer Bio's shares, spread across 190 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 1.43% of GOSS.
The largest institutional holders are Shaw D.E. & Co., Inc. (8.37%), 683 Capital Management LLC (8.01%) and DeepCurrents Investment Group, LLC (7.70%). Together, the top 10 institutions control 48.7% of shares outstanding. In their latest filings, 10 of the top 10 institutions increased their GOSS positions and 0 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of GOSS
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Shaw D.E. & Co., Inc. | 511.99K | 8.37% | +10417.5% |
| 683 Capital Management LLC | 489.99K | 8.01% | +684.0% |
| DeepCurrents Investment Group, LLC | 470.81K | 7.70% | +100.0% |
| Context Capital Management, LLC | 361.83K | 5.92% | +100.0% |
| Worth Venture Partners, Llc | 312.72K | 5.11% | +100.0% |
| AQR Capital Management, LLC | 195.38K | 3.19% | +54.3% |
| GSA Capital Partners LLP | 187.34K | 3.06% | +360.5% |
| Wolverine Asset Management, LLC | 161.18K | 2.64% | +100.0% |
| Renaissance Technologies, LLC | 145.37K | 2.38% | +855.0% |
| Kalehua Capital Management LLC | 139.37K | 2.28% | +8.9% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of GOSS
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 86.39K | 1.41% |
| iShares Trust-iShares Biotechnology ETF | 41.95K | 0.69% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 28.04K | 0.46% |
| SCHWAB STRATEGIC TRUST-Schwab U.S. Small-Cap ETF | 12.34K | 0.20% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 12.21K | 0.20% |
| Invesco Exchange-Traded Fund Trust-Invesco RAFI US 1500 Small-Mid ETF | 6.95K | 0.11% |
| VANGUARD WORLD FUND-Vanguard Health Care Index Fund | 6.77K | 0.11% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 4.76K | 0.08% |
| BlackRock Funds-BlackRock Health Sciences Opportunities Portfolio | 4.57K | 0.07% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 3.75K | 0.06% |
Frequently asked questions
Who is the largest shareholder of Gossamer Bio?
Shaw D.E. & Co., Inc. is the largest institutional shareholder of GOSS, owning 8.37% of shares outstanding (511.99K shares) as of its latest 13F filing.
What percentage of Gossamer Bio is owned by institutions?
Institutions own about 84.9% of GOSS shares and 86.1% of the public float.
How much of Gossamer Bio do insiders own?
Insiders, such as officers and directors, own about 1.43% of GOSS shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.